Mr Simon Pilgrim MA MBBS MD FRCS
Consultant Oncoplastic Breast Surgeon

Simon Pilgrim Breast Care Leicester Consultant Oncoplastic Breast Surgeon
I studied pre-clinical medicine at Cambridge University, graduating with a BA in Neuroscience in 1998. I then moved to the Royal Free Hospital, now part of University College London, for clinical medicine, obtaining my MBBS in 2001.
I developed an interest in breast cancer during my junior surgical jobs at the Luton & Dunstable Hospital and the Norfolk & Norwich University Hospital. To further my interest in breast cancer, I worked in Professor Dylan Edwards’ lab at the University of East Anglia, being awarded my MD in July 2008.
I continued with my higher surgical training in the East of England, where I was able to contribute to a variety of clinical research projects, and was the founding chairman of the East of England Surgical Research Group. Breast cancer remains my main interest, having published previously on the impact of next generation DNA sequencing for BRCA1 mutation carriers. I am now shifting to focus more on national collaborative projects in Oncoplastic Breast Surgery as I feel this is where the biggest gains are to be made in the current evidence underpinning surgical management of breast cancer in the UK.
Having obtained my Fellowship of the Royal College of Surgeons in 2012, I joined Breast Care at the Glenfield Hospital, University Hospitals of Leicester, as a Consultant Oncoplastic Breast Surgeon in 2014, where I am continuing my clinical research interests alongside developing my clinical work as an oncoplastic breast surgeon.
Outside work, I enjoy cycling and motorcycling whenever I can.
Procedures and scope of practice:
As a Consultant Oncoplastic Breast Surgeon in Leicester, I specialise purely in breast surgery . My practice includes surgery for both breast cancer,   benign conditions and cosmetic breast surgery . My patients therefore have access to the full range of operations and procedures such as:
I also offer up-to-date oncoplastic techniques including:
Oncoplastic reshaping
Contralateral symmetrisation including implant augmentation
Lipofilling (lipomodelling or fat transfer)

Cosmetic procedures:
Breast augmentation (enlargement using implants)
Breast reduction
Breast lift (mastopexy)

I work closely with other specialists to ensure that all of my patients have access to the full range of modern diagnostic, surgical and oncological techniques and treatments.


Royal College of Surgeons of England
Association of Breast Surgery
Testimonials from Mr Pilgrim's patients:
​​"I approached the Spire Hospital to pursue breast augmentation and supported by a recommendation from a friend was directed to the Breast Care Leicester surgeon, Mr Pilgrim. I was given a Saturday appointment which was very convenient with a short waiting time.

I met with Mr Pilgrim and his specialist nurse and discussed my wishes. I was received in a professional and sensitive manner, which made me feel valued and respected. Mr Pilgrim was able to clearly explain the options available to me and discuss the various advantages and disadvantages of these. From this consultation I built confidence in his knowledge and experience and felt able to trust him to make the optimal choice for me. It was very comforting and reassuring to gain confidence in the surgeon and I felt very safe. He was able to answer all of my questions and was surprisingly relaxed about the post operative recovery period. I was allowed plenty of time to go through my thoughts and fears and encouraged to go back for a second consultation before committing fully to the procedure.

I wouldn't hesitate to recommend Mr Pilgrim because of his skill and expertise in breast care and his sensitive and genuinely kind approach to his patients."

"I am very pleased with the care I received and I would recommend Mr Pilgrim and his team."
Selected publications

O'Connell RL, Rattay T, Dave RV, Trickey A, Skillman J, Barnes NLP, Gardiner M, Harnett A, Potter S, Holcombe C; iBRA-2 Steering Group; Breast Reconstruction Research Collaborative.
The impact of immediate breast reconstruction on the time to delivery of adjuvant therapy: the iBRA-2 study.
Br J Cancer. 2019 Mar 29. [Epub ahead of print]. PMID: 30923359

Potter S, Conroy EJ, Cutress RI, Williamson PR, Whisker L, Thrush S, Skillman J, Barnes NLP, Mylvaganam S, Teasdale E, Jain A, Gardiner MD, Blazeby JM, Holcombe C; iBRA Steering Group; Breast Reconstruction Research Collaborative.
Short-term safety outcomes of mastectomy and immediate implant-based breast reconstruction with and without mesh (iBRA): a multicentre, prospective cohort study.
Lancet Oncol. 2019 Feb;20(2):254-266. PMID:30639093

Current practice and short-term outcomes of therapeutic mammaplasty in the international TeaM multicentre prospective cohort study.
O'Connell RL, Baker E, Trickey A, Rattay T, Whisker L, Macmillan RD, Potter S; TeaM Steering Group; Mammary Fold Academic and Research Collaborative.
Br J Surg. 2018 Dec;105(13):1778-1792. PMID:30132807

Pilgrim, S. M., Pain, S. J. and Tischkowitz, M. D. 
Opportunities and challenges of next-generation DNA sequencing for breast units. 
Br J Surg. 2014 Jul;101(8):889-98. PMID:24676784

Pilgrim S, Pain S.
Bilateral risk-reducing mastectomy is the safest strategy in BRCA1 carriers.
Eur J Surg Oncol. 2014 Jun;40(6):670-2. PMID:24612652

Douek M, Klaase J, Monypenny I, Kothari A, Zechmeister K, Brown D, Wyld L, Drew P, Garmo H, Agbaje O, Pankhurst Q, Anninga B, Grootendorst M, Ten Haken B, Hall-Craggs MA, Purushotham A, Pinder S; SentiMAG Trialists Group.
Sentinel node biopsy using a magnetic tracer versus standard technique: the SentiMAG Multicentre Trial. 
Ann Surg Oncol. 2014 Apr;21(4):1237-45. PMID:24322530

Burger A, Thurtle D, Owen S, Mannu G, Pilgrim S, Vinayagam R, Pain S.
Sentinel lymph node biopsy for risk-reducing mastectomy.
Breast J. 2013 Sep-Oct;19(5):529-32. PMID:23865803

Hanna MY, Leung E, Rogers C, Pilgrim S.
Primary Large-cell Neuroendocrine Tumor of the Breast.
Breast J. 2013 Mar;19(2):204-6. PMID:23458218

Gutiérrez-Fernández A, Fueyo A, Folgueras AR, Garabaya C, Pennington CJ, Pilgrim S, Edwards DR, Holliday DL, Jones JL, Span PN, Sweep FC, Puente XS, López-Otín C.
Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion.
Cancer Res. 2008 Apr 15;68(8):2755-63. PMID: 18413742

Pilgrim S, Ravichandran D. 
Fine needle aspiration cytology as an adjunct to core biopsy in the assessment of symptomatic breast carcinoma.
The Breast. 2005 Oct;14(5):411-4. PMID: 16216746

"I am extremely happy with my Doctor Pilgrim with the way he did my operation and how much at ease he made me with the follow up of my treatment!"
"Thank you very much to you both and your whole team including the nurses, radiographers and the radiologist for the appointment at Spire on Saturday. I very much appreciated the way you engaged and communicated with me with kindness during the consultation which put me at ease and quickly resolved what is always a concerning issue when finding a lump.”